Literature DB >> 16180935

Impact analysis of signals detected from spontaneous adverse drug reaction reporting data.

Patrick Waller1, Emma Heeley, Jane Moseley.   

Abstract

This paper describes a new method of prioritising signals of potential adverse drug reactions (ADRs) detected from spontaneous reports that is called impact analysis. This is an interim step between signal detection and detailed signal evaluation. Using mathematical screening tools, large numbers of signals may now be detected from spontaneous ADR databases. Regulatory authorities need to rapidly prioritise them and focus on those that are most likely to require significant action. Using two scores ranging from one to 100, each with three input variables, signals may be categorised in terms of the strength of evidence (E) and the potential public health impact (P). In a two-by-two figure with empirically derived cut-off points of ten (the logarithmic mean) for each score, signals are placed in one of four categories (A-D) that are ranked according to their priority (A being the highest and D the lowest). A sensitivity analysis is then performed that tests the robustness of the categorisation in relation to each of the six input variables. A computer program has been written to facilitate the process and reduce error. Further work is required to test the feasibility and value of impact analysis in practice.

Mesh:

Year:  2005        PMID: 16180935     DOI: 10.2165/00002018-200528100-00002

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  9 in total

1.  Determinants of signal selection in a spontaneous reporting system for adverse drug reactions.

Authors:  E P van Puijenbroek; K van Grootheest; W L Diemont; H G Leufkens; A C Egberts
Journal:  Br J Clin Pharmacol       Date:  2001-11       Impact factor: 4.335

2.  Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports.

Authors:  S J Evans; P C Waller; S Davis
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Oct-Nov       Impact factor: 2.890

3.  Automated support for pharmacovigilance: a proposed system.

Authors:  Roselie A Bright; Robert C Nelson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2002-03       Impact factor: 2.890

4.  A model for the future conduct of pharmacovigilance.

Authors:  Patrick C Waller; Stephen J W Evans
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003 Jan-Feb       Impact factor: 2.890

5.  Signal selection and follow-up in pharmacovigilance.

Authors:  Ronald H B Meyboom; Marie Lindquist; Antoine C G Egberts; I Ralph Edwards
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

6.  Practical pharmacovigilance analysis strategies.

Authors:  A Lawrence Gould
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003 Oct-Nov       Impact factor: 2.890

7.  Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring Database.

Authors:  M Ståhl; M Lindquist; I R Edwards; E G Brown
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-06       Impact factor: 2.890

8.  Responding to drug safety issues.

Authors:  P C Waller; E H Lee
Journal:  Pharmacoepidemiol Drug Saf       Date:  1999-12       Impact factor: 2.890

Review 9.  Principles of signal detection in pharmacovigilance.

Authors:  R H Meyboom; A C Egberts; I R Edwards; Y A Hekster; F H de Koning; F W Gribnau
Journal:  Drug Saf       Date:  1997-06       Impact factor: 5.606

  9 in total
  16 in total

1.  Development of a combined system for identification and classification of adverse drug reactions: Alerts Based on ADR Causality and Severity (ABACUS).

Authors:  Yvonne Koh; Chun Wei Yap; Shu-Chuen Li
Journal:  J Am Med Inform Assoc       Date:  2010 Nov-Dec       Impact factor: 4.497

2.  What Is the Plural of a 'Yellow' Anecdote?

Authors:  Stephen J W Evans
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

3.  Testing and implementing signal impact analysis in a regulatory setting: results of a pilot study.

Authors:  Emma Heeley; Patrick Waller; Jane Moseley
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 4.  Perspectives on the use of data mining in pharmaco-vigilance.

Authors:  June Almenoff; Joseph M Tonning; A Lawrence Gould; Ana Szarfman; Manfred Hauben; Rita Ouellet-Hellstrom; Robert Ball; Ken Hornbuckle; Louisa Walsh; Chuen Yee; Susan T Sacks; Nancy Yuen; Vaishali Patadia; Michael Blum; Mike Johnston; Charles Gerrits; Harry Seifert; Karol Lacroix
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

5.  Criteria revision and performance comparison of three methods of signal detection applied to the spontaneous reporting database of a pharmaceutical manufacturer.

Authors:  Yasuyuki Matsushita; Yasufumi Kuroda; Shinpei Niwa; Satoshi Sonehara; Chikuma Hamada; Isao Yoshimura
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

6.  Bias in benefit-risk appraisal in older products: the case of buflomedil for intermittent claudication.

Authors:  Tine L M De Backer; Robert H Vander Stichele; Luc M Van Bortel
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

7.  A model for decision support in signal triage.

Authors:  Bennett Levitan; Chuen L Yee; Leo Russo; Richard Bayney; Adrian P Thomas; Stephen L Klincewicz
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

8.  Development of a novel regulatory pharmacovigilance prioritisation system: an evaluation of its performance at the UK Medicines and Healthcare products Regulatory Agency.

Authors:  Suzie Seabroke; Lesley Wise; Patrick Waller
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

9.  Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation.

Authors:  Francesco Salvo; Emanuel Raschi; Ugo Moretti; Anita Chiarolanza; Annie Fourrier-Réglat; Nicholas Moore; Miriam Sturkemboom; Fabrizio De Ponti; Elisabetta Poluzzi; Antoine Pariente
Journal:  Eur J Clin Pharmacol       Date:  2014-03-05       Impact factor: 2.953

10.  An Automated System Combining Safety Signal Detection and Prioritization from Healthcare Databases: A Pilot Study.

Authors:  Mickael Arnaud; Bernard Bégaud; Frantz Thiessard; Quentin Jarrion; Julien Bezin; Antoine Pariente; Francesco Salvo
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.